Khalif 2009.
Methods | RCT |
Participants | 118 IBS patients (Rome II) |
Interventions | Antispasmodic oral buscopan (20 mg TID) buscopan suppository (30 mg OD) oral drotaverine (80 mg TID) calcium gluconate tablets (1 TID) calendula suppository (OD) |
Outcomes | Pain score |
Notes |